Location History:
- Harvest, AL (US) (2015)
- Waltham, MA (US) (2015)
Company Filing History:
2 out of 1,500 
2 out of 415 
Years Active: 2015
Title: David Richard Jensen: Innovator in Pharmaceutical Conjugates
Introduction
David Richard Jensen is a notable inventor based in Harvest, Alabama, known for his contributions to the field of pharmaceutical conjugates. With a total of 2 patents, Jensen has made significant strides in developing innovative drug formulations that enhance therapeutic efficacy.
Latest Patents
Jensen's latest patents focus on crystalline naloxol-polyethylene glycol (PEG) conjugates. These conjugates are provided in oxalate or phosphate salt forms, including crystalline forms. The patents detail methods of preparing these salt forms and pharmaceutical compositions that comprise them, showcasing Jensen's commitment to advancing drug delivery systems.
Career Highlights
Throughout his career, Jensen has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Nektar Therapeutics. His experience in these organizations has allowed him to refine his expertise in drug development and formulation.
Collaborations
Jensen has collaborated with esteemed professionals in the field, including Carl-Johan Aurell and Martin Hans Bohlin. These partnerships have contributed to the successful development of his innovative pharmaceutical solutions.
Conclusion
David Richard Jensen's work in the realm of pharmaceutical conjugates exemplifies his dedication to innovation and improvement in drug formulations. His patents and collaborations reflect a commitment to enhancing therapeutic options for patients.